DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Quinapril Hydrochloride And Hydrochlorothiazide is a drug marketed by Apotex Corp, Aurobindo Pharma, Invagen Pharms, Mylan, and Sun Pharm Inds Ltd. and is included in five NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
|LaborMed Pharma S.A.||Phase 4|
|Vanderbilt University Medical Center||Phase 4|
|National Center for Research Resources (NCRR)||Phase 4|